INDUSTRY SPONSORED SATELLITE SYMPOSIA - SILVER ROOM
Thursday 7th February 2019
09:00-10:15
Session 2: Satellite Symposium organised by Novartis
Sense of Urgency in CHF: Is there any barrier to optimize therapy of NYHA II patients?
Moderator:
Pierre Troisfontaines – CHR Citadelle Liège, BE
Michel De Pauw - Ghent University Hospital, BE
Back to the future: Key learnings in the treatment of heart failure
Jean-Luc Vachiery - Erasme University Hospital, BE
Panel discussion: Hyde Park speaker's corner - Burning issues in implementing HF therapies
Jean-Luc Vachiery - Erasme University Hospital, BE
Michel de Pauw - UZ Ghent, BE
Pierre Troisfontaines - CHR Citadelle Liège, BE
11:30-12:45
Session 5: Satellite Symposium organised by Servier
How evidence based is your medicine in cardiovascular risk management anno 2019?
Moderators:
Luc Missault - AZ Sint-Jan Bruges, BE
Patrizio Lancellotti - CHU Sart Tilman, BE
Philippe Van de Borne - Erasme Hospital Brussels, BE
From guidelines to evidence-based clinical practice
Krzystof Narkiewicz - Medical University of Gdansk, PL
Are all diuretics equivalent?
Claudio Borghi - University of Bologna, IT
Bradykinine and cardiovascular protection
Arnaud Ancion - CHU Sart Tilman, BE
12:45-13:45
Lunch Session 7: Satellite Symposium organised by Boehringer Ingelheim
The changing face of cardiovascular risk management
Moderators:
Rik Willems - UZ Leuven, BE
Georges Mairesse - Cliniques du Sud Luxembourg, BE
Anticoagulation, bringing it all together in clinical practice
Peter Sinnaeve – UZ Leuven, BE
Past, present & future of SGLT2-inhibitors
Thomas Vanassche - UZ Leuven, BE
Conclusions
Georges Mairesse - Cliniques du Sud Luxembourg, BE
13:45-15:00
Session 9: Satellite Symposium organised by Bayer
Session 9: Satellite Symposium organised by Bayer
From atrial fibrillation to stable coronary and peripheral arterial disease: how to optimize anticoagulation treatment for high risk patients?
Are NOACS a better treatment option for AF-patients with (declining) chronic kidney function?
Moderators:
Peter Sinnaeve - UZ Leuven, BE
Patrizio Lancellotti - CHU Sart Tilman, BE
Are NOACS a better treatment option for AF-patients with (declining) chronic kidney function?
Rogier Caluwé - OLV Aalst, BE
When to combine antiplatelet and anticoagulant agents?
When to combine antiplatelet and anticoagulant agents?
Christophe Beauloye - UCL St-Luc, BE
Friday 8th February 2019
09:00-10:15
Session 14: Satellite Symposium organised by Astra Zeneca
The trilogy of patients at high cardiovascular risk
Moderators:
Patrick Coussement - AZ Sint-Jan Brugge, BE
Sofie Gevaert - UZ Gent, BE
Identification and etiology of high risk CV patients: the prologue
Johan De Sutter - AZ Maria Middelares Gent, BE
Diabetes and ACs: the CV risk continues
Walter Desmet - UZ Leuven, BE
Diabetes and Heart Failure: the epilogue
Christophe Beauloye - UCL St-Luc, BE
10:45-12:00
Session 16: Satellite Symposium organised by Vifor Pharma
Session 16: Satellite Symposium organised by Vifor Pharma
Iron deficiency and hyperkalemia in chronic heart failure: changing the paradigm
Iron deficiency: an important comorbidity in heart failure
Moderators:
Walter Droogne - UZ Leuven, BE
Anne-Catherine Pouleur – UCL Saint-Luc Brussels, BE
Iron deficiency: an important comorbidity in heart failure
Pieter Martens - ZOL Genk, BE
Hyperkalemia management: current treatment approaches
Ileana Piña – Wayne State University & Detroit Medical Center, US
13:00-14:00
Lunch Session 18: Satellite Symposium organised by BMS/Pfizer
Lunch Session 18: Satellite Symposium organised by BMS/Pfizer
NOACs and frail populations: More is less
Polymedicated elderly patients
Moderator:
Georges Mairesse - Cliniques de Sud Luxembourg, BE
Bernard Cosyns - UZ Brussel, BE
Polymedicated elderly patients
Olivier Hanon - Hôpital BROCA Paris, FR
Other frail patients (e.g. worsening renal function, ...)
Other frail patients (e.g. worsening renal function, ...)
Menno Huisman - LUCM Leiden, NL